Recent studies examined miR-103-1 as a treatment strategy for stroke, based on its potential to regulate the expression of the Na+/Ca2+ exchanger (NCX1), which mediates bidirectional flux of calcium and sodium across the synaptic membrane and increases ischemic damage in rat brain (111). This evidence concerns the gene SLC8A1 and stroke disorder.